China to add more cancer drugs to reimbursement list, talks end in Sept: Xinhua
China plans to add a range of cancer drugs to medicines eligible for reimbursement from the government, the official Xinhua news agency said on Saturday, adding that negotiations on pricing with manufacturers should be finished by end-September.
